Companies / BAX vs WST
BAX vs WST: Baxter International and West Pharmaceutical Services
Baxter International (BAX) reported $11.2B in revenue against a -8.5% net margin, while West Pharmaceutical Services (WST) reported $3.1B at a 16.1% net margin, most recently.
| Metric | BAX | WST |
|---|---|---|
| Revenue | $11.2B | $3.1B |
| Net Income | $-1.0B | $0.5B |
| Gross Margin | 30.1% | 35.9% |
| Operating Margin | -2.7% | 19.0% |
| EPS (Diluted) | $-1.87 | $6.79 |
| Free Cash Flow | $0.3B | $0.5B |
| Total Debt | $9.5B | $0.2B |
| P/E Ratio | n/m | 40.5× |
| P/B Ratio | n/m | 6.2× |
| Stock Price | $25.64 | $392.32 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BAX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $12.1B | $10.1B | $10.4B | $10.6B | $11.2B |
| WST Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |